Author

Fabio Blandini

University of PaviaORCID 0000-0002-0178-1289Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Andrea M. WeinsteiniD· 1 shared Claudia P. González-HuntiD· 1 shared Dario R. AlessiiD· 1 shared Esther M. SammleriD· 1 shared Fox BioNet (FBN) investigators· 1 shared Francesca TonelliiD· 1 shared Jeremy P. RouanetiD· 1 shared Kirk I. EricksoniD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Andrea M. WeinsteinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeurosciencebioRxivPreprintFeb 7, 2022

A mitochondrial blood-based patient stratification candidate biomarker for Parkinson's disease

Rui Qi, Esther M. Sammler, Claudia P. González-Hunt…·Laurie H. Sanders

The paper identifies mtDNA damage as a blood-based biomarker for Parkinson's disease, showing increased levels in early-stage patients and mutation carriers, suggesting its potential for patient stratification in clinical trials.

4 citations

humanDNA methylation

𝕏 PostBluesky